- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04305340
Bio-signal Telemonitoring Using Electronic Textiles in a Pediatric Population
July 6, 2023 updated by: Aamir Jeewa
There is a need for developing reliable and convenient technologies for telemonitoring of physiological signals such as respiration, cardiac function, and activity level in children and especially for those with heart disease.
Changing symptomatology causes heart failure patients to seek medical attention in order to be assessed and potentially have medication adjusted or additional testing being undertaken.
These frequent clinical encounters affect the quality of life of these children and their parents, as well as being costly for the health care system.
A textile based technology for telemonitoring application that is comfortable and accurate in its data collection can help to provide real time information on physiologic parameters.
The primary research objective is to determine the feasibility and validity of a textile-enabled sensor system in measuring physiologic variables, or "biological signals", related to cardiopulmonary function in children.
The study will include 10 patients with heart failure, and 10 healthy controls.
Study Overview
Study Type
Interventional
Enrollment (Actual)
20
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Ontario
-
Toronto, Ontario, Canada, M5G1X8
- The Hospital for Sick Children
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
10 years to 18 years (Child, Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria
Healthy children participants (i.e. without CHD or HF) aged between 10 to 18 years with normal electrocardiograms and normal echocardiograms (i.e. screens for familial cardiomyopathy).
OR
- Patients aged between 10 and 18 years with diagnosed congenital heart disease or cardiomyopathies referred to pediatric cardiology ambulatory clinic at SickKids.
Exclusion Criteria
- In-hospital patients.
- Patients too ill to participate or perform any activity.
- Patients with Fontan/single ventricle physiology circulation.
- Children who are less than 6 months post op from a cardiac surgery as they will have concerns from an activity and wound care standpoint.
- Participants with known allergies to adhesives (as reported by family).
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: SKIIN Textile Device in children with healthy hearts
The Myant SKIIN Device will be worn by study participants while they lay down, sit, stand, exercise and cool-down.
|
|
|
Experimental: SKIIN Textile Device in children with heart failure
The Myant SKIIN Device will be worn by study participants while they lay down, sit, stand, exercise and cool-down
|
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Validate the heart rate measurements obtained using the SKIIN Textile in children with and without heart disease.
Time Frame: 40 minutes
|
Validate the heart rate measurements obtained using the SKIIN Textile in children with and without heart disease compared to the measurements obtained by the Grael 4K PSG
|
40 minutes
|
|
Validate the respiratory rate measurements obtained using the SKIIN Textile in children with and without heart disease.
Time Frame: 40 minutes
|
Validate the respiratory rate measurements obtained using the SKIIN Textile in children with and without heart disease compared to the measurements obtained by the Grael 4K PSG.
|
40 minutes
|
|
Validate the pulse oximetry measurements obtained using the SKIIN Textile in children with and without heart disease.
Time Frame: 40 minutes
|
Validate the pulse oximetry measurements obtained using the SKIIN Textile in children with and without heart disease compared to the measurements obtained by the Nonin, WristOx2TM, Model 3150, Wrist-worn Pulse Oximeter
|
40 minutes
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
To extract and analyze temperature data obtained using the SKIIN Textile in children with
Time Frame: 40 minutes
|
To extract and analyze temperature data obtained using the SKIIN Textile in children with
|
40 minutes
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Aamir Jeewa, MD, The Hospital for Sick Children
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 15, 2021
Primary Completion (Actual)
April 1, 2022
Study Completion (Actual)
March 30, 2023
Study Registration Dates
First Submitted
November 29, 2019
First Submitted That Met QC Criteria
March 9, 2020
First Posted (Actual)
March 12, 2020
Study Record Updates
Last Update Posted (Actual)
July 7, 2023
Last Update Submitted That Met QC Criteria
July 6, 2023
Last Verified
July 1, 2023
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- CTO 1891
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Heart Failure
-
Indiana UniversityRecruitingCongestive Heart Failure | Congestive Heart Failure (CHF) | Congestive Heart Failure Chronic | Congestive Heart Failure(CHF)United States
-
University of Health Sciences LahoreRecruitingAcute Decompensated Heart Failure | Heart Failure, Diastolic | Heart Failure, SystolicPakistan
-
Tufts Medical CenterMetro West Medical CenterCompletedCongestive Heart Failure | Diastolic Heart Failure | Systolic Heart FailureUnited States
-
Abbott Medical DevicesCompletedHeart Failure | Heart Failure, Diastolic | Heart Failure, Systolic | Heart Failure NYHA Class II | Heart Failure NYHA Class III | Heart Failure With Reduced Ejection Fraction | Heart Failure NYHA Class IV | Heart Failure With Normal Ejection Fraction | Heart Failure; With Decompensation | Heart Failure...United States, Canada
-
Manipal UniversityUnknownHeart Failure | Decompensated Heart Failure | Acute Heart Failure | Diastolic Heart Failure | Systolic Heart FailureIndia
-
Lakeland Regional Health Systems, Inc.RecruitingHeart Failure | Heart Failure Acute | Acute Heart Failure (AHF) | Heart Failure - NYHA II - IVUnited States
-
VA Eastern Colorado Health Care SystemNational Institute on Aging (NIA)CompletedHeart Failure | Heart Failure, Diastolic | Heart Failure, Systolic | Heart Failure With Reduced Ejection Fraction | Heart Failure With Preserved Ejection Fraction | Heart Failure; With Decompensation | Heart Failure,Congestive | Heart Failure AcuteUnited States
-
Eli Lilly and CompanyNot yet recruitingHeart Failure | Heart Failure, Diastolic | Heart Failure, SystolicUnited States, Japan
-
Wake Forest UniversityCompletedHeart Failure, Congestive | Heart Failure With Preserved Ejection Fraction
-
Wake Forest UniversityNational Institute on Aging (NIA)CompletedHeart Failure, Congestive | Diastolic Heart FailureUnited States
Clinical Trials on Myant SKIIN Device
-
The Hospital for Sick ChildrenMyant Medical Corp.Recruiting
-
Baqiyatallah Medical Sciences UniversityTehran University of Medical Sciences; Hamadan University of Medical Science; Tabriz University of Medical SciencesNot yet recruitingSkin Ulcer | Pressure Ulcer | Pressure Injury | Decubitus Ulcer | Pressure Sore | Bed Sore | Decubitus Sore
-
Myant Medical Corp.Partners in Advanced Cardiac EvaluationCompleted
-
Myant Medical Corp.University of WaterlooCompleted
-
Myant Medical Corp.University of WaterlooRecruiting
-
Myant Medical Corp.Jodha Tishon IncRecruiting
-
Myant Medical Corp.McMaster UniversityNot yet recruiting
-
ResMedKlinEra Global ServicesNot yet recruitingObstructive Sleep ApneaAustralia
-
Facet TechnologiesLifeScanCompletedDiabetesUnited States
-
Karolinska InstitutetUnknownDegenerative Disc Disease | Discogenic Low Back PainSweden